JP2021502366A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021502366A5 JP2021502366A5 JP2020525851A JP2020525851A JP2021502366A5 JP 2021502366 A5 JP2021502366 A5 JP 2021502366A5 JP 2020525851 A JP2020525851 A JP 2020525851A JP 2020525851 A JP2020525851 A JP 2020525851A JP 2021502366 A5 JP2021502366 A5 JP 2021502366A5
- Authority
- JP
- Japan
- Prior art keywords
- intraocular implant
- lactide
- weight
- intrinsic viscosity
- poly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007943 implant Substances 0.000 claims 8
- 229920001244 Poly(D,L-lactide) Polymers 0.000 claims 3
- AQOKCDNYWBIDND-FTOWTWDKSA-N bimatoprost Chemical compound CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1 AQOKCDNYWBIDND-FTOWTWDKSA-N 0.000 claims 3
- 229960002470 bimatoprost Drugs 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 2
- 239000002202 Polyethylene glycol Substances 0.000 claims 2
- 229920002988 biodegradable polymer Polymers 0.000 claims 2
- 239000004621 biodegradable polymer Substances 0.000 claims 2
- 239000011159 matrix material Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- 229920003178 (lactide-co-glycolide) polymer Polymers 0.000 claims 1
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical group O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims 1
- JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 claims 1
- 208000010412 Glaucoma Diseases 0.000 claims 1
- 206010030043 Ocular hypertension Diseases 0.000 claims 1
- 210000002159 anterior chamber Anatomy 0.000 claims 1
- 238000002513 implantation Methods 0.000 claims 1
- 230000004410 intraocular pressure Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024000170A JP2024032731A (ja) | 2017-11-09 | 2024-01-04 | 効果の持続期間が延長された眼内圧降下用徐放性インプラント |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762583967P | 2017-11-09 | 2017-11-09 | |
| US62/583,967 | 2017-11-09 | ||
| US201862683337P | 2018-06-11 | 2018-06-11 | |
| US62/683,337 | 2018-06-11 | ||
| PCT/US2018/059910 WO2019094652A1 (en) | 2017-11-09 | 2018-11-09 | Sustained-release implants for lowering intraocular pressure with extended duration of effect |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024000170A Division JP2024032731A (ja) | 2017-11-09 | 2024-01-04 | 効果の持続期間が延長された眼内圧降下用徐放性インプラント |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021502366A JP2021502366A (ja) | 2021-01-28 |
| JP2021502366A5 true JP2021502366A5 (https=) | 2021-12-16 |
Family
ID=64457124
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020525851A Pending JP2021502366A (ja) | 2017-11-09 | 2018-11-09 | 効果の持続期間が延長された眼内圧降下用徐放性インプラント |
| JP2024000170A Abandoned JP2024032731A (ja) | 2017-11-09 | 2024-01-04 | 効果の持続期間が延長された眼内圧降下用徐放性インプラント |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024000170A Abandoned JP2024032731A (ja) | 2017-11-09 | 2024-01-04 | 効果の持続期間が延長された眼内圧降下用徐放性インプラント |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20190192341A1 (https=) |
| EP (1) | EP3706717A1 (https=) |
| JP (2) | JP2021502366A (https=) |
| KR (1) | KR20200086289A (https=) |
| CN (1) | CN111315361A (https=) |
| AU (2) | AU2018366214B2 (https=) |
| BR (1) | BR112020009224A2 (https=) |
| CA (1) | CA3080908A1 (https=) |
| CL (1) | CL2020001183A1 (https=) |
| CO (1) | CO2020006924A2 (https=) |
| IL (1) | IL273946A (https=) |
| MX (2) | MX2020004730A (https=) |
| PH (1) | PH12020550550A1 (https=) |
| RU (1) | RU2020113494A (https=) |
| SG (1) | SG11202004126XA (https=) |
| WO (1) | WO2019094652A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105682645B (zh) * | 2013-10-31 | 2019-09-06 | 阿勒根公司 | 含前列腺酰胺的眼内植入物及其使用方法 |
| GB2601922B (en) | 2019-06-27 | 2024-04-24 | Layerbio Inc | Ocular device drub delivery systems |
| CA3166738A1 (en) | 2020-02-06 | 2021-08-12 | Charles D. Blizzard | Travoprost compositions and methods for treating ocular diseases |
| EP3884929B1 (en) | 2020-03-25 | 2023-06-14 | Ocular Therapeutix, Inc. | Ocular implant containing a tyrosine kinase inhibitor |
| WO2022011321A1 (en) | 2020-07-10 | 2022-01-13 | Allergan, Inc. | Posterior chamber delivery device for sustained release implant |
| BR112023001073A2 (pt) * | 2020-07-21 | 2023-03-07 | Allergan Inc | Implante intraocular com alto carregamento de prostamida |
| CN120897764A (zh) | 2023-04-11 | 2025-11-04 | 视尔普斯眼科公司 | 包含阿西替尼多晶型物iv的眼部植入物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5834498A (en) | 1992-09-21 | 1998-11-10 | Allergan | Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| US5688819A (en) | 1992-09-21 | 1997-11-18 | Allergan | Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| US7799336B2 (en) | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
| US7993634B2 (en) * | 2004-04-30 | 2011-08-09 | Allergan, Inc. | Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods |
| EP3085358B1 (en) * | 2010-01-22 | 2017-11-01 | Allergan, Inc. | Intracameral sustained release therapeutic agent implants |
| US20120276186A1 (en) * | 2011-04-29 | 2012-11-01 | Ghebremeskel Alazar N | Sustained release latanoprost implant |
| CN105682645B (zh) * | 2013-10-31 | 2019-09-06 | 阿勒根公司 | 含前列腺酰胺的眼内植入物及其使用方法 |
| MX2016007345A (es) * | 2013-12-06 | 2016-12-09 | Envisia Therapeutics Inc | Implante intracameral para el tratamiento de una condicion ocular. |
| EP3324890A4 (en) * | 2015-07-23 | 2019-06-19 | Allergan, Inc. | GLACO-TREATMENT VIA INTRAKAMERAL EYE IMPLANTS |
-
2018
- 2018-11-08 US US16/184,834 patent/US20190192341A1/en not_active Abandoned
- 2018-11-09 JP JP2020525851A patent/JP2021502366A/ja active Pending
- 2018-11-09 BR BR112020009224-0A patent/BR112020009224A2/pt unknown
- 2018-11-09 SG SG11202004126XA patent/SG11202004126XA/en unknown
- 2018-11-09 AU AU2018366214A patent/AU2018366214B2/en not_active Expired - Fee Related
- 2018-11-09 KR KR1020207014585A patent/KR20200086289A/ko not_active Withdrawn
- 2018-11-09 RU RU2020113494A patent/RU2020113494A/ru unknown
- 2018-11-09 EP EP18808193.9A patent/EP3706717A1/en active Pending
- 2018-11-09 WO PCT/US2018/059910 patent/WO2019094652A1/en not_active Ceased
- 2018-11-09 CN CN201880072815.7A patent/CN111315361A/zh active Pending
- 2018-11-09 CA CA3080908A patent/CA3080908A1/en active Pending
- 2018-11-09 MX MX2020004730A patent/MX2020004730A/es unknown
-
2020
- 2020-04-13 IL IL273946A patent/IL273946A/en unknown
- 2020-05-04 PH PH12020550550A patent/PH12020550550A1/en unknown
- 2020-05-05 CL CL2020001183A patent/CL2020001183A1/es unknown
- 2020-06-05 CO CONC2020/0006924A patent/CO2020006924A2/es unknown
- 2020-07-13 MX MX2023011426A patent/MX2023011426A/es unknown
-
2023
- 2023-05-22 US US18/200,064 patent/US20240225893A9/en not_active Abandoned
-
2024
- 2024-01-04 JP JP2024000170A patent/JP2024032731A/ja not_active Abandoned
- 2024-10-22 AU AU2024227541A patent/AU2024227541A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021502366A5 (https=) | ||
| JP2013518049A5 (https=) | ||
| US11517422B2 (en) | Intraocular implants comprising drug-eluting materials with time release characteristics | |
| Gimbel et al. | Results of bilateral cataract extraction with posterior chamber intraocular lens implantation in children | |
| US12096941B2 (en) | Methods for forming a nerve barrier | |
| CN103179927B (zh) | 青光眼阀、用于容纳青光眼阀的壳体和包含该阀和/或该壳体的青光眼引流装置 | |
| CN107756781B (zh) | 一种疝补片及其制备方法 | |
| JP2025120178A (ja) | バイオポリマー組成物、足場及びデバイス | |
| AU2012225499B2 (en) | Shape memory polymer intraocular lenses | |
| US20220409902A1 (en) | Methods and devices for nerve regeneration | |
| US20120203160A1 (en) | Implants for reducing intraocular pressure | |
| AU2010292490B2 (en) | Fixation of opthalmic implants | |
| RU2020113494A (ru) | Имплантаты с замедленным высвобождением для снижения внутриглазного давления с увеличенной продолжительностью действия | |
| US20190314548A1 (en) | Extracellular Matrix Implant | |
| Han et al. | In vitro and in vivo study of lens refilling with poloxamer hydrogel | |
| RU2012134271A (ru) | Полимерный гелевый состав | |
| RU2484794C1 (ru) | Способ имплантации и фиксации интраокулярной линзы при обширных дефектах задней капсулы хрусталика | |
| Peng et al. | Biodegradable balloon‐expandable self‐locking polycaprolactone stents as buckling explants for the treatment of retinal detachment: An in vitro and in vivo study | |
| JP2017502808A (ja) | 眼科用粘性手術用具 | |
| Parel et al. | Intraocular implants for the surgical correction of presbyopia | |
| RU2613418C1 (ru) | Способ имплантации искусственной иридохрусталиковой диафрагмы при аниридии и афакии, осложненной отсутствием капсулы хрусталика | |
| Lane | The Acrysof Toric IOL’s FDA trial results | |
| Agarwal et al. | Reply: Fibrin glue–assisted sutureless scleral fixation | |
| CN1175900C (zh) | Ctla-4眼用制剂 | |
| HK40044640A (en) | Drug eluting coating for medical devices |